Carl Zeiss Meditec AG (CZMWY)
34.16
-0.98
(-2.79%)
USD |
OTCM |
Oct 05, 16:00
Carl Zeiss Meditec Max Drawdown (5Y) : 88.28% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 88.28% |
| August 31, 2026 | 88.28% |
| July 31, 2026 | 88.28% |
| June 30, 2026 | 88.28% |
| May 31, 2026 | 88.28% |
| April 30, 2026 | 88.28% |
| March 31, 2026 | 88.28% |
| February 28, 2026 | 86.80% |
| January 31, 2026 | 85.49% |
| December 31, 2025 | 79.90% |
| November 30, 2025 | 79.90% |
| October 31, 2025 | 79.90% |
| September 30, 2025 | 79.90% |
| August 31, 2025 | 79.90% |
| July 31, 2025 | 79.90% |
| June 30, 2025 | 79.90% |
| May 31, 2025 | 79.90% |
| April 30, 2025 | 79.90% |
| March 31, 2025 | 79.90% |
| February 28, 2025 | 79.90% |
| January 31, 2025 | 79.90% |
| December 31, 2024 | 79.43% |
| November 30, 2024 | 74.99% |
| October 31, 2024 | 73.19% |
| September 30, 2024 | 73.19% |
| Date | Value |
|---|---|
| August 31, 2024 | 71.58% |
| July 31, 2024 | 71.58% |
| June 30, 2024 | 70.10% |
| May 31, 2024 | 66.51% |
| April 30, 2024 | 66.51% |
| March 31, 2024 | 66.51% |
| February 29, 2024 | 66.51% |
| January 31, 2024 | 66.51% |
| December 31, 2023 | 66.51% |
| November 30, 2023 | 66.51% |
| October 31, 2023 | 66.51% |
| September 30, 2023 | 63.61% |
| August 31, 2023 | 59.15% |
| July 31, 2023 | 56.67% |
| June 30, 2023 | 56.67% |
| May 31, 2023 | 56.67% |
| April 30, 2023 | 56.67% |
| March 31, 2023 | 56.67% |
| February 28, 2023 | 56.67% |
| January 31, 2023 | 56.67% |
| December 31, 2022 | 56.67% |
| November 30, 2022 | 56.67% |
| October 31, 2022 | 56.67% |
| September 30, 2022 | 56.67% |
| August 31, 2022 | 52.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| IDEXX Laboratories, Inc. | 54.00% |
| Neogen Corp. | 90.92% |
| QuidelOrtho Corp. | 94.30% |
| Smith & Nephew plc | 55.07% |
| Trinity Biotech Plc | 98.43% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -46.54 |
| Beta (5Y) | 1.488 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.95% |
| Historical Sharpe Ratio (5Y) | -0.7369 |
| Historical Sortino (5Y) | -1.227 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.55% |